[18F]BTK-1: A Novel Positron Emission Tomography Tracer for Imaging Bruton’s Tyrosine Kinase
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology
Link
https://link.springer.com/content/pdf/10.1007/s11307-022-01733-1.pdf
Reference22 articles.
1. Burger JA, Wiestner A (2018) Targeting B cell receptor signalling in cancer: preclinical and clinical advances. Nat Rev Cancer 18:148–167
2. Pal Singh S, Dammeijer F, Hendriks RW (2018) Role of Bruton’s tyrosine kinase in B cells and malignancies. Mol Cancer 17:57
3. Lucas F, Woyach JA (2019) Inhibiting Bruton’s Tyrosine Kinase in CLL and Other B-Cell Malignancies. Target Oncol 14:125–138
4. Jacobs L, Habringer S, Slawska J et al (2017) Functional imaging in combination with mutation status aids prediction of response to inhibiting B-cell receptor signaling in lymphoma. Oncotarget 8:78917–78929
5. Dahl K, Turner T, Vasdev N (2020) Radiosynthesis of a Bruton’s tyrosine kinase inhibitor, [(11) C]Tolebrutinib, via palladium-NiXantphos-mediated carbonylation. J Label Compd Radiopharm 63:482–487
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Labeling of Bruton’s Tyrosine Kinase (BTK) Inhibitor [11C]BIO-2008846 in Three Different Positions and Measurement in NHP Using PET;International Journal of Molecular Sciences;2024-07-18
2. Preliminary PET imaging of [11C]evobrutinib in mouse models of colorectal cancer, SARS‐CoV‐2, and lung damage: Radiosynthesis via base‐aided palladium‐NiXantphos‐mediated11C‐carbonylation;Journal of Labelled Compounds and Radiopharmaceuticals;2023-09-10
3. Synthesis and Preclinical Evaluation of a Novel Fluorine-18-Labeled Tracer for Positron Emission Tomography Imaging of Bruton’s Tyrosine Kinase;ACS Pharmacology & Translational Science;2023-02-10
4. Pipeline Impact of Radiolabeled Compounds in Drug Discovery and Development;ACS Medicinal Chemistry Letters;2022-09-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3